Cargando…

Impact of autologous HSCT on the quality of life and fatigue in patients with relapsing multiple sclerosis

In this study, we aimed to assess the quality of life, fatigue, anxiety, and depression after Autologous haematopoietic stem cell transplantation (AHSCT) and to investigate its impact of on separate domains of health status and fatigue in patients with multiple sclerosis (MS). Overall, 18 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giedraitiene, N., Gasciauskaite, G., Kaubrys, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470541/ https://www.ncbi.nlm.nih.gov/pubmed/36100664 http://dx.doi.org/10.1038/s41598-022-19748-7

Ejemplares similares

Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis
por: Giedraitiene, Natasa, et al.
Publicado: (2018)

Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests
por: Giedraitiene, Natasa, et al.
Publicado: (2019)

Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis
por: Giedraitiene, N., et al.
Publicado: (2020)

Relationship between cognition and treatment adherence to disease-modifying therapy in multiple sclerosis: a prospective, cross-sectional study
por: Giedraitiene, N., et al.
Publicado: (2022)

The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration
por: Giedraitienė, Nataša, et al.
Publicado: (2015)

Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability
por: Giedraitiene, Natasa, et al.
Publicado: (2015)

Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study
por: Giedraitiene, Natasa, et al.
Publicado: (2021)

The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis
por: Ghaem, Haleh, et al.
Publicado: (2008)

Successful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT)
por: Sivgin, Serdar, et al.
Publicado: (2013)

The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids
por: Rakusa, Martin, et al.
Publicado: (2023)

Quality of life in multiple sclerosis: The differential impact of motor and cognitive fatigue
por: David Ruban, Sabina, et al.
Publicado: (2021)

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis
por: Afolabi, Dayo, et al.
Publicado: (2017)

Assessment of Fatigue and Quality of Life in Multiple Sclerosis Patients: A Cross-Sectional Study
por: Chemingui, S., et al.
Publicado: (2023)

Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial
por: Wahls, Terry L, et al.
Publicado: (2021)

Impact of depression and fatigue on relapsing remitting multiple sclerosis in Kingdom of Saudi Arabia
por: Alshamrani, Foziah J., et al.
Publicado: (2020)

Prevalence of fatigue in patients with multiple sclerosis and its effect on the quality of life
por: Nagaraj, Karthik, et al.
Publicado: (2013)

The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis
por: Stroud, Nicole M, et al.
Publicado: (2009)

Impact of Natalizumab Treatment on Fatigue, Mood, and Aspects of Cognition in Relapsing–Remitting Multiple Sclerosis
por: Kunkel, Annett, et al.
Publicado: (2015)

Characterization of the T-cell Repertoire after Autologous HSCT in Patients with Ankylosing Spondylitis
por: Komech, E. A., et al.
Publicado: (2018)

The effect of evening primrose oil on fatigue and quality of life in patients with multiple sclerosis
por: Majdinasab, Nastaran, et al.
Publicado: (2018)

The Role of Iron Metabolism in Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients
por: Knyszyńska, Anna, et al.
Publicado: (2020)

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life
por: Planas, Raquel, et al.
Publicado: (2014)

Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study
por: Quispe-Cabanillas, Juan G, et al.
Publicado: (2012)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
por: Kizlaitienandedot, Rasa, et al.
Publicado: (2017)

Fatigue in Chinese Patients With Amyotrophic Lateral Sclerosis: Associated Factors and Impact on Quality of Life
por: An, Ran, et al.
Publicado: (2022)

The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis
por: Hadgkiss, Emily J, et al.
Publicado: (2015)

Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot study
por: Bisht, Babita, et al.
Publicado: (2015)

Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment
por: Tervonen, Tommi, et al.
Publicado: (2023)

The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial
por: Fox, Robert J, et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
por: Bertolotto, Antonio, et al.
Publicado: (2020)

Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex
por: Hatam, Nahid, et al.
Publicado: (2016)

HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT
por: Gu, Ha Ra, et al.
Publicado: (2015)

The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis
por: Rodgers, Stephanie, et al.
Publicado: (2021)

Influence of Transcranial Direct Current Stimulation and Exercise on Fatigue and Quality of Life in Multiple Sclerosis
por: Muñoz-Paredes, Inés, et al.
Publicado: (2022)

The Effect of Fatigue and Pain Self- Efficacy on Health-Related Quality of Life Among Patients with Multiple Sclerosis
por: Adamopoulou, Fevronia, et al.
Publicado: (2019)

The impact of quality of life on treatment preferences in multiple sclerosis patients
por: Lee Mortensen, Gitte, et al.
Publicado: (2017)

The impact of disease characteristics on multiple sclerosis patients’ quality of life
por: Rezapour, Aziz, et al.
Publicado: (2017)

Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
por: Baliu-Piqué, Mariona, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4a4usctucgk4qtlg5qopvm1cbb